Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma
Clinical trial NCT03349255 · TERMINATED
Trial details
- NCT number
- NCT03349255
- Sponsor
- Aeon Therapeutics (Shanghai) Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-06
- Primary completion
- 2019-01-10
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.